4d hails ‘significant step forward’ in research update

MEDICAL research company 4d Pharma has given a second positive research update in three days.

Since floating on AIM last year, shares in the Manchester company have defied a sometimes turbulent stock market to more than double to 435p. The stock rose again in early trading to 464.5p, up nearly 7%.

4d's latest news focuses on the MicroRx Platform which is developing new live bacteria to create bioterapeutics to treat inflammatory and auto-immune diseases.

It began working on MicroRX  in May 2014, an... For the full story register now for free or login below...

Close